aminolevulinic acid has been researched along with Parasitemia in 1 studies
Aminolevulinic Acid: A compound produced from succinyl-CoA and GLYCINE as an intermediate in heme synthesis. It is used as a PHOTOCHEMOTHERAPY for actinic KERATOSIS.
5-aminolevulinic acid : The simplest delta-amino acid in which the hydrogens at the gamma position are replaced by an oxo group. It is metabolised to protoporphyrin IX, a photoactive compound which accumulates in the skin. Used (in the form of the hydrochloride salt)in combination with blue light illumination for the treatment of minimally to moderately thick actinic keratosis of the face or scalp.
Parasitemia: The presence of parasites (especially malarial parasites) in the blood. (Dorland, 27th ed)
| Excerpt | Relevance | Reference |
|---|---|---|
| "5-Aminolevulinic acid (ALA) is a naturally occurring amino acid present in diverse organisms and a precursor of heme biosynthesis." | 5.42 | In vivo curative and protective potential of orally administered 5-aminolevulinic acid plus ferrous ion against malaria. ( Balogun, EO; Hikosaka, K; Kita, K; Kobayashi, F; Komatsuya, K; Nakajima, M; Niikura, M; Suzuki, S; Takahashi, K; Tanaka, T, 2015) |
| "Parasitemia was monitored in the infected mice, and elimination of the parasites was confirmed using diagnostic PCR." | 5.42 | In vivo curative and protective potential of orally administered 5-aminolevulinic acid plus ferrous ion against malaria. ( Balogun, EO; Hikosaka, K; Kita, K; Kobayashi, F; Komatsuya, K; Nakajima, M; Niikura, M; Suzuki, S; Takahashi, K; Tanaka, T, 2015) |
| "5-Aminolevulinic acid (ALA) is a naturally occurring amino acid present in diverse organisms and a precursor of heme biosynthesis." | 1.42 | In vivo curative and protective potential of orally administered 5-aminolevulinic acid plus ferrous ion against malaria. ( Balogun, EO; Hikosaka, K; Kita, K; Kobayashi, F; Komatsuya, K; Nakajima, M; Niikura, M; Suzuki, S; Takahashi, K; Tanaka, T, 2015) |
| "Parasitemia was monitored in the infected mice, and elimination of the parasites was confirmed using diagnostic PCR." | 1.42 | In vivo curative and protective potential of orally administered 5-aminolevulinic acid plus ferrous ion against malaria. ( Balogun, EO; Hikosaka, K; Kita, K; Kobayashi, F; Komatsuya, K; Nakajima, M; Niikura, M; Suzuki, S; Takahashi, K; Tanaka, T, 2015) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Suzuki, S | 1 |
| Hikosaka, K | 1 |
| Balogun, EO | 1 |
| Komatsuya, K | 1 |
| Niikura, M | 1 |
| Kobayashi, F | 1 |
| Takahashi, K | 1 |
| Tanaka, T | 1 |
| Nakajima, M | 1 |
| Kita, K | 1 |
1 other study available for aminolevulinic acid and Parasitemia
| Article | Year |
|---|---|
In vivo curative and protective potential of orally administered 5-aminolevulinic acid plus ferrous ion against malaria.
Topics: Aminolevulinic Acid; Animals; Body Weight; Disease Models, Animal; Female; Malaria; Mice; Mice, Inbr | 2015 |